Residency Positions

One candidate is selected each year for the PGY2 Solid Organ Transplant Pharmacy Residency at Beth Israel Deaconess Medical Center. The program begins annually on July 1.

Residency Eligibility

Qualifications for participation in the PGY2 Solid Organ Transplant Pharmacy Residency Program are in accordance with criteria set forth by the American Society of Health System Pharmacists (ASHP).

  • Graduate of an ASHP Accredited PGY1 Pharmacy training degree program
  • Graduate of an Accreditation Council for Pharmacy Education (ACPE)-accredited Doctor of Pharmacy degree program.
  • Residents must be licensed or eligible for licensure in order to be licensed in MA within 90 days of the commencement of the residency.
  • Residents must be authorized to work in the United States on a full-time basis. Work authorization sponsorship for this position is unavailable.
  • Residents shall participate in and obey the rules of the American Society of Health-System Pharmacists (ASHP) Resident Matching Program

Application Deadline

Your application and all supporting documentation must be received by January 4th of the year you wish to begin the program.

Application Materials

Application templates are available electronically using the Pharmacy Online Residency Centralized Application (PhORCAS). All applicants must provide the following:

  1. Letter of Interest, including a statement of professional goals and reasons for pursuing a PGY2 Solid Organ Transplant Pharmacy Residency
  2. Curriculum Vitae
  3. Three Letters of Recommendation
  4. Official Pharmacy School Transcript

Submission of Application Materials

Applications to the BIDMC PGY2 Solid Organ Transplant Residency program are to be submitted electronically using the Pharmacy Online Residency Centralized Application (PhORCAS).

Personal Interview

Applicants considered for an appointment will be invited to visit BIDMC for a personal interview with the program director and selected faculty. An interview can be arranged only when your application file is complete.

  1. Completed application packets will be reviewed by select members of the Residency Advisory Committee (RAC) to determine candidates that most closely match the BIDMC program goals and opportunities.
  2. Selected candidates will be invited to an onsite interview with members of the Transplant Pharmacy team, the Residency Program Director, physicians, as well as Pharmacy Management. The interview will include a short (15 minute) patient vignette presentation to the group.
  3. Following the interview process, residency candidates will be ranked based upon the collaborative input with regard the interviews and qualifications of the candidate.
  4. A rank list will be submitted to the Resident Matching Program.

Acknowledgment of Residency Match

Residents matched to the BIDMC Residency program will receive an acceptance letter acknowledging the match and delineating the general terms and conditions of the residency. Acknowledgment in writing by the resident will constitute acceptance of the match and agreement to fulfill the duties of the residency position for the upcoming year.

Pharmacy Licensure Verification

Participation in the BIDMC PGY2 Solid Organ Transplant Residency Program is contingent on securing and maintaining a license without restriction in the State of Massachusetts. It is the expectation that the resident will complete these licensure requirements within 60 days of the commencement of the program.
The resident will provide the Residency Program Director confirmation that:

  • He/she has already taken or is scheduled to take the NAPLEX and the Multistate Pharmacy Jurisprudence Examination (MPJE), or
  • He/she will take the MPJE upon successful transfer of NAPLEX scores from another state, or
  • He/she has already has a valid MA pharmacy license. 
  • Upon notification of successful completion of the NAPLEX and/or MPJE the resident will provide documentation of licensure to the Residency Program Director.
  • Failure to attain licensure is grounds for dismissal from the residency program. Residents should contact the Residency Program Director should any issue arise with licensure.